Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03837665
Other study ID # STUDY00140843
Secondary ID
Status Recruiting
Phase Phase 1/Phase 2
First received
Last updated
Start date May 2, 2018
Est. completion date June 30, 2019

Study information

Verified date February 2019
Source University of Kansas Medical Center
Contact Kevin Sykes, PhD
Phone 913-588-7154
Email ksykes@kumc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

By doing this study, researchers hope to find out if platelet rich plasma (PRP) can heal holes in the eardrum as an alternative to surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who meet criteria for tympanoplasty procedure

- Willing to comply with the protocol and attend all study visits

- Able to provide written informed consent

Exclusion Criteria:

- Patients who have previously undergone middle ear or lateral skull base surgery

- Patients who would not qualify for a tympanoplasty

- Any type of platelet disorder, cancer, or ongoing systemic infection

- Any type of hemodynamic instability, septicemia, infection, tobacco use, any use of steroids to the ear drums

- Type I diabetes or other autoimmune pathology

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Platelet Rich Plasma
Platelet Rich Plasma (PRP) is blood plasma that has been enriched with platelets.

Locations

Country Name City State
United States University of Kansas Medical Center Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevention of patients requiring surgery Number of participants that are able to avoid surgery for their perforation. 6 Weeks
Secondary Time to healing Size of perforation 6 Weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04635228 - Biodesign® Otologic Repair Graft
Active, not recruiting NCT00222417 - Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease Phase 2/Phase 3
Recruiting NCT05086718 - Composite Cartilage Perichondrium Graft for Air Bone Gap Closure in Chronic Suppurative Otitis Media (CSOM) Without Posterior Meatal Flap N/A
Withdrawn NCT03904316 - Use of Biodesign® Otologic Graft in Tympanoplasty Phase 4
Completed NCT02307916 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Terminated NCT01766856 - Eustachian Tube Function and Myringoplasty/Tympanoplasty N/A
Recruiting NCT06260618 - Effect of Chitodex Gel in Tympanoplasty Surgery N/A
Recruiting NCT04960384 - Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations Phase 2
Not yet recruiting NCT06257602 - Microscopic Versus Endoscopic Tympanoplasty
Completed NCT02550314 - A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18 Phase 3
Not yet recruiting NCT00310349 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease Phase 3
Not yet recruiting NCT03416725 - Evaluation of Prognostic Factors in Tympanoplasty N/A
Not yet recruiting NCT04428463 - Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia N/A
Completed NCT00714064 - PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers Phase 3
Completed NCT05605262 - Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Phase 2/Phase 3
Completed NCT02296944 - Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child N/A
Recruiting NCT05849844 - Tympanoseal Clinical Study N/A
Not yet recruiting NCT04687995 - Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty N/A
Completed NCT02120651 - Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty Phase 3
Withdrawn NCT03028272 - Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty N/A